EA
TRAW icon

Emerald Advisers’s Traws Pharma TRAW Stock Holding History

Emerald Advisers’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7
Closed -$4.22M – 377
2013
Q4 		$4.22M Buy
7
+2
+40% +$1.89M 0.23% 139
2013
Q3 		$6.9M Buy
+5
New +$7.15M 0.39% 84

Other funds holding TRAW

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Advisers's TRAW Position: Q1 2014 in Review

Emerald Advisers sold out of Traws Pharma (TRAW) in Q1 2014, closing a stake of 7 shares — an estimated $4.22M sold.

Emerald Advisers first reported a position in TRAW in Q3 2013 and held it in 2 quarters. The position peaked at $6.9M in Q3 2013. 16 funds tracked by Wall St. Rank hold TRAW as of Q1 2014.

  • Emerald Advisers reported no remaining Traws Pharma position as of Q1 2014 after selling out during the quarter.
  • Emerald Advisers sold 7 Traws Pharma shares in Q1 2014, an estimated $4.22M.
  • Emerald Advisers first reported a position in Traws Pharma in Q3 2013 and held it in 2 quarters.
  • Emerald Advisers's Traws Pharma position peaked at $6.9M in Q3 2013.
  • 16 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2014.

Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.